Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Elaine Perry
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Procedures
Physiology
Sign-in to see full Profile
Network (preview)
171
Perry, Robert
64
Court, Jennifer
54
McKeith, Ian
47
Ballard, Clive
44
Piggott, Margaret
22
Jaros, Evelyn
21
Fairbairn, Andrew
21
O'Brien, John
14
Johnson, M
13
Martin-Ruiz, Carmen
13
Morris, Christopher
12
Lloyd, S
12
Ince, Paul
10
Marshall, EF
9
Spurden, DP
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Elaine Perry (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sabbagh Marwan N; Adler Charles H; Lahti Tyson J; Connor Donald J; Vedders Linda; Peterson Lars K; Caviness John N; Shill Holly A; Sue Lucia I; Ziabreva Iryna; Perry Elaine; Ballard Clive G; Aarsland Dag; Walker Douglas G; Beach Thomas G
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.
Alzheimer disease and associated disorders 2009;23(3):295-7.
-
2009: Chalmers Katy A; Wilcock Gordon K; Vinters Harry V; Perry Elaine K; Perry Robert; Ballard Clive G; Love Seth
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
Journal of neurology 2009;256(5):717-20.
-
2008: Huang Liping; Abuhamdah Sawsan; Howes Melanie-Jayne R; Dixon Christine L; Elliot Mark S J; Ballard Clive; Holmes Clive; Burns Alistair; Perry Elaine K; Francis Paul T; Lees George; Chazot Paul L
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.
The Journal of pharmacy and pharmacology 2008;60(11):1515-22.
-
2008: Kalaria Raj N; Maestre Gladys E; Arizaga Raul; Friedland Robert P; Galasko Doug; Hall Kathleen; Luchsinger José A; Ogunniyi Adesola; Perry Elaine K; Potocnik Felix; Prince Martin; Stewart Robert; Wimo Anders; Zhang Zhen-Xin; Antuono Piero;
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.
Lancet neurology 2008;7(9):812-26.
-
2008: Tasker Andrea; Ballard Clive G; Joachim Catharine; Warden Donald R; Okello Edward J; Perry Robert H; Khan Nadeem; Smith A David; Lehmann Donald J; Perry Elaine K
Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
Neuroscience letters 2008;442(3):297-9.
-
2008: MacInnes Nicholas; Iravani Mahmoud M; Perry Elaine; Piggott Margaret; Perry Robert; Jenner Peter; Ballard Clive
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):869-78.
-
2008: Scholey Andrew B; Tildesley Nicola T J; Ballard Clive G; Wesnes Keith A; Tasker Andrea; Perry Elaine K; Kennedy David O
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.
Psychopharmacology 2008;198(1):127-39.
-
2008: Warren Naomi M; Piggott Margaret A; Lees Andrew J; Perry Elaine K; Burn David J
Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.
Journal of chemical neuroanatomy 2008;35(3):268-74.
-
2008: O'Brien John T; Colloby Sean J; Pakrasi Sanjeet; Perry Elaine K; Pimlott Sally L; Wyper David J; McKeith Ian G; Williams E David
Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations.
NeuroImage 2008;40(3):1056-63.
-
2008: Abuhamdah Sawsan; Huang Liping; Elliott Mark S J; Howes Melanie-Jayne R; Ballard Clive; Holmes Clive; Burns Alistair; Perry Elaine K; Francis Paul T; Lees George; Chazot Paul L
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.
The Journal of pharmacy and pharmacology 2008;60(3):377-84.
-
2008: Sharp Sally I; Ballard Clive G; Ziabreva Iryna; Piggott Margaret A; Perry Robert H; Perry Elaine K; Aarsland Dag; Ehrt Uwe; Larsen Jan P; Francis Paul T
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.
Dementia and geriatric cognitive disorders 2008;26(4):330-8.
-
2007: Piggott Margaret A; Ballard Clive G; Rowan Elise; Holmes Clive; McKeith Ian G; Jaros Evelyn; Perry Robert H; Perry Elaine K
Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
Synapse (New York, N.Y.) 2007;61(11):903-11.
-
2007: Ziabreva I; Ballard C; Johnson M; Larsen J P; McKeith I; Perry R; Aarsland D; Perry E
Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit.
Neuropathology and applied neurobiology 2007;33(5):586-90.
-
2007: Francis Paul T; Perry Elaine K
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 17():S351-7.
-
2007: Pakrasi Sanjeet; Colloby Sean J; Firbank Michael J; Perry Elaine K; Wyper David J; Owens Jonathan; McKeith Ian G; Williams E David; O'Brien John T
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
Journal of neurology 2007;254(7):907-13.
-
2007: Ballard C G; Chalmers K A; Todd C; McKeith I G; O'Brien J T; Wilcock G; Love S; Perry E K
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Neurology 2007;68(20):1726-9.
-
2007: Perry Elaine
Commentary: botanical potentials in Alzheimer's disease.
Journal of alternative and complementary medicine (New York, N.Y.) 2007;13(3):345-6.
-
2007: O'Brien J T; Colloby S J; Pakrasi S; Perry E K; Pimlott S L; Wyper D J; McKeith I G; Williams E D
Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.
Journal of neurology, neurosurgery, and psychiatry 2007;78(4):356-62.
-
2007: Piggott Margaret A; Ballard Clive G; Dickinson Heather O; McKeith Ian G; Perry Robert H; Perry Elaine K
Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(2):231-44.
-
2006: Ballard C; Ziabreva I; Perry R; Larsen J P; O'Brien J; McKeith I; Perry E; Aarsland D
Differences in neuropathologic characteristics across the Lewy body dementia spectrum.
Neurology 2006;67(11):1931-4.
-
2006: Colloby Sean J; Pakrasi Sanjeet; Firbank Michael J; Perry Elaine K; Piggott Margaret A; Owens Jonathan; Wyper David J; McKeith Ian G; Burn David J; Williams E David; O'Brien John T
In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
NeuroImage 2006;33(2):423-9.
-
2006: Ziabreva Iryna; Perry Elaine; Perry Robert; Minger Stephen L; Ekonomou Antigoni; Przyborski Stefan; Ballard Clive
Altered neurogenesis in Alzheimer's disease.
Journal of psychosomatic research 2006;61(3):311-6.
-
2006: Thomas A J; Hendriksen M; Piggott M; Ferrier I N; Perry E; Ince P; O'Brien J T
A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression.
Neuropathology and applied neurobiology 2006;32(3):296-303.
-
2006: Ziabreva Iryna; Ballard Clive G; Aarsland Dag; Larsen Jan-Petter; McKeith Ian G; Perry Robert H; Perry Elaine K
Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism.
Neurobiology of aging 2006;27(3):433-8.
-
2006: Sahin Huseyin A; Emre Murat; Ziabreva Iryna; Perry Elaine; Celasun Bulent; Perry Robert
The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies.
Acta neuropathologica 2006;111(2):115-25.
-
2006: Pimlott Sally L; Piggott Margaret; Ballard Clive; McKeith Ian; Perry Robert; Kometa Simon; Owens Jonathan; Wyper David; Perry Elaine
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.
Neurobiology of disease 2006;21(1):50-6.
-
2006: Perry Nicolette; Perry Elaine
Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.
CNS drugs 2006;20(4):257-80.
-
2005: Collerton Daniel; Perry Elaine; McKeith Ian
Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.
The Behavioral and brain sciences 2005;28(6):737-57; discussion 757-94.
-
2005: McKeith I G; Dickson D W; Lowe J; Emre M; O'Brien J T; Feldman H; Cummings J; Duda J E; Lippa C; Perry E K; Aarsland D; Arai H; Ballard C G; Boeve B; Burn D J; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz C G; Gomez-Tortosa E; Halliday G; Hansen L A; Hardy J; Iwatsubo T; Kalaria R N; Kaufer D; Kenny R A; Korczyn A; Kosaka K; Lee V M Y; Lees A; Litvan I; Londos E; Lopez O L; Minoshima S; Mizuno Y; Molina J A; Mukaetova-Ladinska E B; Pasquier F; Perry R H; Schulz J B; Trojanowski J Q; Yamada M;
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology 2005;65(12):1863-72.
-
2005: Court J A; Johnson M; Religa D; Keverne J; Kalaria R; Jaros E; McKeith I G; Perry R; Naslund J; Perry E K
Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking.
Neuropathology and applied neurobiology 2005;31(5):522-35.
-
2005: Ballard C G; Perry R H; McKeith I G; Perry E K
Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.
International journal of geriatric psychiatry 2005;20(9):872-5.
-
2005: Ray M A; Graham A J; Lee M; Perry R H; Court J A; Perry E K
Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus.
Neurobiology of disease 2005;19(3):366-77.
-
2005: Teaktong Thanasak; Piggott Margaret A; Mckeith Ian G; Perry Robert H; Ballard Clive G; Perry Elaine K
Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
Behavioural brain research 2005;161(2):299-305.
-
2005: Aarsland Dag; Perry Robert; Larsen Jan P; McKeith Ian G; O'Brien John T; Perry Elaine K; Burn David; Ballard Clive G
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
The Journal of clinical psychiatry 2005;66(5):633-7.
-
2005: Warren N M; Piggott M A; Perry E K; Burn D J
Cholinergic systems in progressive supranuclear palsy.
Brain : a journal of neurology 2005;128(Pt 2):239-49.
-
2005: Bohr I J; Ray M A; McIntosh J M; Chalon S; Guilloteau D; McKeith I G; Perry R H; Clementi F; Perry E K; Court J A; Piggott M A
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
Experimental neurology 2005;191(2):292-300.
-
2005: Tasker Andrea; Perry Elaine K; Ballard Clive G
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Expert review of neurotherapeutics 2005;5(1):101-6.
-
2005: Perry E; Ziabreva I; Perry R; Aarsland D; Ballard C
Absence of cholinergic deficits in "pure" vascular dementia.
Neurology 2005;64(1):132-3.
-
2005: Tildesley N T J; Kennedy D O; Perry E K; Ballard C G; Wesnes K A; Scholey A B
Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers.
Physiology & behavior 2005;83(5):699-709.
-
2005: Ballard Clive; Morris Christopher; Kalaria Rajesh; McKeith Ian; Perry Robert; Perry Elaine
The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.
Dementia and geriatric cognitive disorders 2005;19(5-6):357-60.
-
2004: Ray Melissa; Bohr Iwo; McIntosh J Michael; Ballard Clive; McKeith Ian; Chalon Sylvie; Guilloteau Denis; Perry Robert; Perry Elaine; Court J A; Piggott Margaret
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
Neuroscience letters 2004;372(3):220-5.
-
2004: Mukaetova-Ladinska E B; Arnold H; Jaros E; Perry R; Perry E
Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.
Neuropathology and applied neurobiology 2004;30(6):615-23.
-
2004: Teaktong Thanasak; Graham Alison J; Court Jennifer A; Perry Robert H; Jaros Evelyn; Johnson Mary; Hall Ros; Perry Elaine K
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Journal of the neurological sciences 2004;225(1-2):39-49.
-
2004: Okello Edward J; Savelev Sergey U; Perry Elaine K
In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia.
Phytotherapy research : PTR 2004;18(8):624-7.
-
2004: Belmonte M K; Cook E H; Anderson G M; Rubenstein J L R; Greenough W T; Beckel-Mitchener A; Courchesne E; Boulanger L M; Powell S B; Levitt P R; Perry E K; Jiang Y H; DeLorey T M; Tierney E
Autism as a disorder of neural information processing: directions for research and targets for therapy.
Molecular psychiatry 2004;9(7):646-63.
-
2004: Teaktong T; Graham A J; Johnson M; Court J A; Perry E K
Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.
Neuropathology and applied neurobiology 2004;30(3):243-54.
-
2004: Hellström-Lindahl Ewa; Court Jennifer; Keverne Jessica; Svedberg Marie; Lee Mandy; Marutle Amelia; Thomas Alan; Perry Elaine; Bednar Ivan; Nordberg Agneta
Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice.
The European journal of neuroscience 2004;19(10):2703-10.
-
2004: Ballard Clive G; Jacoby Robin; Del Ser Teodoro; Khan M Nadeem; Munoz David G; Holmes Clive; Nagy Zsuzanna; Perry Elaine K; Joachim Catherine; Jaros Evelyn; O'Brien John T; Perry Robert H; McKeith Ian G
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
The American journal of psychiatry 2004;161(5):843-9.
-
2004: Savelev Sergey U; Okello Edward J; Perry Elaine K
Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents.
Phytotherapy research : PTR 2004;18(4):315-24.
-
2004: Martin-Ruiz C M; Lee M; Perry R H; Baumann M; Court J A; Perry E K
Molecular analysis of nicotinic receptor expression in autism.
Brain research. Molecular brain research 2004;123(1-2):81-90.
-
2004: Pimlott S L; Piggott M; Owens J; Greally E; Court J A; Jaros E; Perry R H; Perry E K; Wyper D
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(1):108-16.
-
2004: McKeith Ian G; Wesnes Keith A; Perry Elaine; Ferrara Roberto
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Dementia and geriatric cognitive disorders 2004;18(1):94-100.
-
2004: Perry Elaine K; Perry Robert H
Neurochemistry of consciousness: cholinergic pathologies in the human brain.
Progress in brain research 2004;145():287-99.
-
2003: Martin-Ruiz Carmen M; Haroutunian Vahram H; Long Philip; Young Allan H; Davis Kenneth L; Perry Elaine K; Court Jennifer A
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
Biological psychiatry 2003;54(11):1222-33.
-
2003: Kennedy D O; Wake G; Savelev S; Tildesley N T J; Perry E K; Wesnes K A; Scholey A B
Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(10):1871-81.
-
2003: Perry Elaine K; Kilford Linda; Lees Andrew J; Burn David J; Perry Robert H
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs.
Annals of neurology 2003;54(2):235-8.
-
2003: Tildesley N T J; Kennedy D O; Perry E K; Ballard C G; Savelev S; Wesnes K A; Scholey A B
Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers.
Pharmacology, biochemistry, and behavior 2003;75(3):669-74.
-
2003: Savelev S; Okello E; Perry N S L; Wilkins R M; Perry E K
Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil.
Pharmacology, biochemistry, and behavior 2003;75(3):661-8.
-
2003: Perry Nicolette S L; Bollen Chloe; Perry Elaine K; Ballard Clive
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial.
Pharmacology, biochemistry, and behavior 2003;75(3):651-9.
-
2003: Perry Elaine; McKeith Ian; Ballard Clive
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies.
Neurology 2003;60(11):1852-3.
-
2003: Piggott Margaret A; Owens Jonathan; O'Brien John; Colloby Sean; Fenwick John; Wyper David; Jaros Evelyn; Johnson Mary; Perry Robert H; Perry Elaine K
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
Journal of chemical neuroanatomy 2003;25(3):161-73.
-
2003: Graham A J; Ray M A; Perry E K; Jaros E; Perry R H; Volsen S G; Bose S; Evans N; Lindstrom J; Court J A
Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus.
Journal of chemical neuroanatomy 2003;25(2):97-113.
-
2003: Hanning C D; Blokland A; Johnson M; Perry E K
Effects of repeated anaesthesia on central cholinergic function in the rat cerebral cortex.
European journal of anaesthesiology 2003;20(2):93-7.
-
2003: McKeith Ian G; Burn David J; Ballard Clive G; Collerton Daniel; Jaros Evelyn; Morris Chris M; McLaren Andrew; Perry Elaine K; Perry Robert; Piggott Margaret A; O'Brien John T
Dementia with Lewy bodies.
Seminars in clinical neuropsychiatry 2003;8(1):46-57.
-
2003: Teaktong Thanasak; Graham Alison; Court Jennifer; Perry Robert; Jaros Evelyn; Johnson Mary; Hall Ros; Perry Elaine
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
Glia 2003;41(2):207-11.
-
2003: Court Jenny A; Perry Elaine K
Neurotransmitter abnormalities in vascular dementia.
International psychogeriatrics / IPA 2003;15 Suppl 1():81-7.
-
2002: Martin-Ruiz C; Lawrence S; Piggott M; Kuryatov A; Lindstrom J; Gotti C; Cookson M R; Perry R H; Jaros E; Perry E K; Court J A
Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.
Neuroscience letters 2002;335(2):134-8.
-
2002: Ballard Clive G; Court Jennifer A; Piggott Margaret; Johnson Mary; O'Brien John; McKeith Ian; Holmes Clive; Lantos Peter; Jaros Evelyn; Perry Robert; Perry E
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex.
Consciousness and cognition 2002;11(3):461-74.
-
2002: Piggott Margaret; Owens Jonathan; O'Brien John; Paling Sean; Wyper David; Fenwick John; Johnson Mary; Perry Robert; Perry Elaine
Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.
Journal of chemical neuroanatomy 2002;24(3):211-23.
-
2002: Ballard Clive G; O'Brien John T; Reichelt Katharina; Perry Elaine K
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.
The Journal of clinical psychiatry 2002;63(7):553-8.
-
2002: Lee M; Martin-Ruiz C; Graham A; Court J; Jaros E; Perry R; Iversen P; Bauman M; Perry E
Nicotinic receptor abnormalities in the cerebellar cortex in autism.
Brain : a journal of neurology 2002;125(Pt 7):1483-95.
-
2002: Kennedy D O; Scholey Andrew B; Tildesley N T J; Perry E K; Wesnes K A
Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).
Pharmacology, biochemistry, and behavior 2002;72(4):953-64.
-
2002: Bednar Ivan; Paterson David; Marutle Amelia; Pham Therese M; Svedberg Marie; Hellström-Lindahl Ewa; Mousavi Malahat; Court Jennifer; Morris Christopher; Perry Elaine; Mohammed Abdul; Zhang Xiao; Nordberg Agneta
Selective nicotinic receptor consequences in APP(SWE) transgenic mice.
Molecular and cellular neurosciences 2002;20(2):354-65.
-
2002: Svedberg Marie M; Svensson Anne-Lie; Johnson Mary; Lee Mandy; Cohen Osnat; Court Jennifer; Soreq Hermona; Perry Elaine; Nordberg Agneta
Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.
Journal of molecular neuroscience : MN 2002;18(3):211-22.
-
2002: Ballard Clive; Johnson Mary; Piggott Margaret; Perry Robert; O'Brien John; Rowan Elise; Perry Elaine; Lantos Peter; Cairns Nigel; Holmes Clive
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.
Journal of affective disorders 2002;69(1-3):219-23.
-
2002: Nordberg Agneta; Hellström-Lindahl Ewa; Lee Mandy; Johnson Mary; Mousavi Malahat; Hall Ros; Perry Elaine; Bednar Ivan; Court Jennifer
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).
Journal of neurochemistry 2002;81(3):655-8.
-
2002: Perry N S L; Houghton P J; Jenner P; Keith A; Perry E K
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2002;9(1):48-51.
-
2002: Graham A; Court J A; Martin-Ruiz C M; Jaros E; Perry R; Volsen S G; Bose S; Evans N; Ince P; Kuryatov A; Lindstrom J; Gotti C; Perry E K
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum.
Neuroscience 2002;113(3):493-507.
-
2001: Court J A; Ballard C G; Piggott M A; Johnson M; O'Brien J T; Holmes C; Cairns N; Lantos P; Perry R H; Jaros E; Perry E K
Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.
Pharmacology, biochemistry, and behavior 2001;70(4):571-9.
-
2001: Perry N S; Houghton P J; Sampson J; Theobald A E; Hart S; Lis-Balchin M; Hoult J R; Evans P; Jenner P; Milligan S; Perry E K
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease.
The Journal of pharmacy and pharmacology 2001;53(10):1347-56.
-
2001: Marutle A; Zhang X; Court J; Piggott M; Johnson M; Perry R; Perry E; Nordberg A
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.
Journal of chemical neuroanatomy 2001;22(1-2):115-26.
-
2001: Perry E K; Lee M L; Martin-Ruiz C M; Court J A; Volsen S G; Merrit J; Folly E; Iversen P E; Bauman M L; Perry R H; Wenk G L
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.
The American journal of psychiatry 2001;158(7):1058-66.
-
2001: Perry E K; Martin-Ruiz C M; Court J A
Nicotinic receptor subtypes in human brain related to aging and dementia.
Alcohol (Fayetteville, N.Y.) 2001;24(2):63-8.
-
2001: Court J; Martin-Ruiz C; Piggott M; Spurden D; Griffiths M; Perry E
Nicotinic receptor abnormalities in Alzheimer's disease.
Biological psychiatry 2001;49(3):175-84.
-
2001: Kalaria R N; Ballard C G; Ince P G; Kenny R A; McKeith I G; Morris C M; O'Brien J T; Perry E K; Perry R H; Edwardson J A
Multiple substrates of late-onset dementia: implications for brain protection.
Novartis Foundation symposium 2001;235():49-60; discussion 60-5.
-
2000: Court J A; Martin-Ruiz C; Graham A; Perry E
Nicotinic receptors in human brain: topography and pathology.
Journal of chemical neuroanatomy 2000;20(3-4):281-98.
-
2000: Ballard C; Piggott M; Johnson M; Cairns N; Perry R; McKeith I; Jaros E; O'Brien J; Holmes C; Perry E
Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.
Annals of neurology 2000;48(6):868-76.
-
2000: Walker M P; Ayre G A; Perry E K; Wesnes K; McKeith I G; Tovee M; Edwardson J A; Ballard C G
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease.
Dementia and geriatric cognitive disorders 2000;11(6):327-35.
-
2000: Martin-Ruiz C M; Piggott M; Gotti C; Lindstrom J; Mendelow A D; Siddique M S; Perry R H; Perry E K; Court J A
Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease.
Neuropharmacology 2000;39(13):2830-9.
-
2000: Perry N S; Houghton P J; Theobald A; Jenner P; Perry E K
In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes.
The Journal of pharmacy and pharmacology 2000;52(7):895-902.
-
2000: McKeith I G; Grace J B; Walker Z; Byrne E J; Wilkinson D; Stevens T; Perry E K
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
International journal of geriatric psychiatry 2000;15(5):387-92.
-
2000: Perry E; Martin-Ruiz C; Lee M; Griffiths M; Johnson M; Piggott M; Haroutunian V; Buxbaum J D; Nãsland J; Davis K; Gotti C; Clementi F; Tzartos S; Cohen O; Soreq H; Jaros E; Perry R; Ballard C; McKeith I; Court J
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
-
2000: McKeith I G; Ballard C G; Perry R H; Ince P G; O'Brien J T; Neill D; Lowery K; Jaros E; Barber R; Thompson P; Swann A; Fairbairn A F; Perry E K
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.
Neurology 2000;54(5):1050-8.
-
2000: Wake G; Court J; Pickering A; Lewis R; Wilkins R; Perry E
CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory.
Journal of ethnopharmacology 2000;69(2):105-14.
-
2000: Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
Acta neurologica Scandinavica. Supplementum 2000;176():34-41.
-
2000: Court J A; Piggott M A; Lloyd S; Cookson N; Ballard C G; McKeith I G; Perry R H; Perry E K
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Neuroscience 2000;98(1):79-87.
-
1999: Martin-Ruiz C M; Court J A; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry R H; Perry E K
Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
Journal of neurochemistry 1999;73(4):1635-40.
-
1999: Court J; Spurden D; Lloyd S; McKeith I; Ballard C; Cairns N; Kerwin R; Perry R; Perry E
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.
Journal of neurochemistry 1999;73(4):1590-7.
-
1999: McKeith I G; Perry E K; Perry R H
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.
Neurology 1999;53(5):902-5.
-
1999: Piggott M A; Marshall E F; Thomas N; Lloyd S; Court J A; Jaros E; Burn D; Johnson M; Perry R H; McKeith I G; Ballard C; Perry E K
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Brain : a journal of neurology 1999;122 ( Pt 8)():1449-68.
-
1999: Mantle D; Falkous G; Perry E K
Effect of flavonoids on protease activities in human skeletal muscle tissue in vitro.
Clinica chimica acta; international journal of clinical chemistry 1999;285(1-2):13-20.
-
1999: Ballard C; Holmes C; McKeith I; Neill D; O'Brien J; Cairns N; Lantos P; Perry E; Ince P; Perry R
Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.
The American journal of psychiatry 1999;156(7):1039-45.
-
1999: Perry E; Walker M; Grace J; Perry R
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Trends in neurosciences 1999;22(6):273-80.
-
1999: Perry E K; Pickering A T; Wang W W; Houghton P J; Perry N S
Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy.
The Journal of pharmacy and pharmacology 1999;51(5):527-34.
-
1999: Piggott M A; Marshall E F; Thomas N; Lloyd S; Court J A; Jaros E; Costa D; Perry R H; Perry E K
Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Neuroscience 1999;90(2):433-45.
-
1999: Lewis R; Wake G; Court G; Court J A; Pickering A T; Kim Y C; Perry E K
Non-ginsenoside nicotinic activity in ginseng species.
Phytotherapy research : PTR 1999;13(1):59-64.
-
1999: Goodchild R E; Court J A; Hobson I; Piggott M A; Perry R H; Ince P; Jaros E; Perry E K
Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases.
The European journal of neuroscience 1999;11(2):449-56.
-
1999: Lippa C F; Smith T W; Perry E
Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(5-6):525-35.
-
1998: Terzano S; Court J A; Fornasari D; Griffiths M; Spurden D P; Lloyd S; Perry R H; Perry E K; Clementi F
Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease.
Brain research. Molecular brain research 1998;63(1):72-8.
-
1998: Perry E
Cholinergic mechanisms and cognitive decline.
European journal of anaesthesiology 1998;15(6):768-73.
-
1998: Court J A; Lloyd S; Thomas N; Piggott M A; Marshall E F; Morris C M; Lamb H; Perry R H; Johnson M; Perry E K
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.
Neuroscience 1998;87(1):63-78.
-
1998: Piggott M A; Perry E K; Marshall E F; McKeith I G; Johnson M; Melrose H L; Court J A; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry R H
Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
Biological psychiatry 1998;44(8):765-74.
-
1998: Lyras L; Perry R H; Perry E K; Ince P G; Jenner A; Jenner P; Halliwell B
Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.
Journal of neurochemistry 1998;71(1):302-12.
-
1998: Murdoch I; Perry E K; Court J A; Graham D I; Dewar D
Cortical cholinergic dysfunction after human head injury.
Journal of neurotrauma 1998;15(5):295-305.
-
1998: Ince P G; Perry E K; Morris C M
Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?
Brain pathology (Zurich, Switzerland) 1998;8(2):299-324.
-
1998: Perry E K; Pickering A T; Wang W W; Houghton P; Perry N S
Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence.
Journal of alternative and complementary medicine (New York, N.Y.) 1998;4(4):419-28.
-
1998: Perry E; Court J; Goodchild R; Griffiths M; Jaros E; Johnson M; Lloyd S; Piggott M; Spurden D; Ballard C; McKeith I; Perry R
Clinical neurochemistry: developments in dementia research based on brain bank material.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(8-9):915-33.
-
1997: Thompson J; Thomas N; Singleton A; Piggott M; Lloyd S; Perry E K; Morris C M; Perry R H; Ferrier I N; Court J A
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
Pharmacogenetics 1997;7(6):479-84.
-
1997: Perry E; Kay D W
Some developments in brain ageing and dementia.
British journal of biomedical science 1997;54(3):201-15.
-
1997: Spurden D P; Court J A; Lloyd S; Oakley A; Perry R; Pearson C; Pullen R G; Perry E K
Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding.
Journal of chemical neuroanatomy 1997;13(2):105-13.
-
1997: Court J A; Lloyd S; Johnson M; Griffiths M; Birdsall N J; Piggott M A; Oakley A E; Ince P G; Perry E K; Perry R H
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging.
Brain research. Developmental brain research 1997;101(1-2):93-105.
-
1997: Marshall E F; Perry R H; Perry E K; Piggott M A; Thompson P; Jaros E; Burn D J
Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration.
Acta neurologica Scandinavica 1997;95(5):287-92.
-
1997: Perry R; McKeith I; Perry E
Lewy body dementia--clinical, pathological and neurochemical interconnections.
Journal of neural transmission. Supplementum 1997;51():95-109.
-
1996: McKeith I G; Galasko D; Kosaka K; Perry E K; Dickson D W; Hansen L A; Salmon D P; Lowe J; Mirra S S; Byrne E J; Lennox G; Quinn N P; Edwardson J A; Ince P G; Bergeron C; Burns A; Miller B L; Lovestone S; Collerton D; Jansen E N; Ballard C; de Vos R A; Wilcock G K; Jellinger K A; Perry R H
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.
Neurology 1996;47(5):1113-24.
-
1996: Johnson M; Perry R H; Piggott M A; Court J A; Spurden D; Lloyd S; Ince P G; Perry E K
Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging.
Neurobiology of aging 1996;17(4):639-51.
-
1996: Mantle D; Falkous G; Ishiura S; Blanchard P J; Perry E K
Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Clinica chimica acta; international journal of clinical chemistry 1996;249(1-2):129-39.
-
1996: Perry E K; Court J A; Lloyd S; Johnson M; Griffiths M H; Spurden D; Piggott M A; Turner J; Perry R H
Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe.
Annals of the New York Academy of Sciences 1996;777():388-92.
-
1996: Morris C M; Massey H M; Benjamin R; Leake A; Broadbent C; Griffiths M; Lamb H; Brown A; Ince P G; Tyrer S; Thompson P; McKeith I G; Edwardson J A; Perry R H; Perry E K
Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.
Journal of neural transmission. Supplementum 1996;47():205-18.
-
1995: Court J A; Perry E K; Spurden D; Griffiths M; Kerwin J M; Morris C M; Johnson M; Oakley A E; Birdsall N J; Clementi F
The role of the cholinergic system in the development of the human cerebellum.
Brain research. Developmental brain research 1995;90(1-2):159-67.
-
1995: Perry E K; Perry R H
Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.
Brain and cognition 1995;28(3):240-58.
-
1995: Mantle D; Falkous G; Ishiura S; Perry R H; Perry E K
Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Journal of the neurological sciences 1995;131(1):65-70.
-
1995: Perry E K; Morris C M; Court J A; Cheng A; Fairbairn A F; McKeith I G; Irving D; Brown A; Perry R H
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Neuroscience 1995;64(2):385-95.
-
1995: Strong C; Anderton B H; Perry R H; Perry E K; Ince P G; Lovestone S
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
Alzheimer disease and associated disorders 1995;9(4):218-22.
-
1995: Perry E
Cholinergic signaling in Alzheimer disease: therapeutic strategies.
Alzheimer disease and associated disorders 1995;9 Suppl 2():1-2.
-
1994: Harrington C R; Louwagie J; Rossau R; Vanmechelen E; Perry R H; Perry E K; Xuereb J H; Roth M; Wischik C M
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
The American journal of pathology 1994;145(6):1472-84.
-
1994: Court J A; Perry E K; Spurden D; Lloyd S; Gillespie J I; Whiting P; Barlow R
Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (alpha 4 beta 2) transfected into mouse fibroblasts with ion channel activity.
Brain research 1994;667(1):118-22.
-
1994: Rubboli F; Court J A; Sala C; Morris C; Chini B; Perry E; Clementi F
Distribution of nicotinic receptors in the human hippocampus and thalamus.
The European journal of neuroscience 1994;6(10):1596-604.
-
1994: Harrington C R; Perry R H; Perry E K; Hurt J; McKeith I G; Roth M; Wischik C M
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
Dementia (Basel, Switzerland) 1994;5(5):215-28.
-
1994: Rubboli F; Court J A; Sala C; Morris C; Perry E; Clementi F
Distribution of neuronal nicotinic receptor subunits in human brain.
Neurochemistry international 1994;25(1):69-71.
-
1994: Raghavan R; Khin-Nu C; Brown A G; Day K A; Tyrer S P; Ince P G; Perry E K; Perry R H
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21).
Neuroreport 1994;5(11):1393-6.
-
1994: Piggott M A; Perry E K; McKeith I G; Marshall E; Perry R H
Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.
Lancet 1994;343(8904):1044-5.
-
1994: Perry E K; Haroutunian V; Davis K L; Levy R; Lantos P; Eagger S; Honavar M; Dean A; Griffiths M; McKeith I G
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
Neuroreport 1994;5(7):747-9.
-
1994: Perry E K; Kerwin J M; Perry R H
On neuronal ill health.
Trends in neurosciences 1994;17(2):51-2.
-
1994: Levy R; Eagger S; Griffiths M; Perry E; Honavar M; Dean A; Lantos P
Lewy bodies and response to tacrine in Alzheimer's disease.
Lancet 1994;343(8890):176.
-
1993: Perry E K; Piggott M A; Court J A; Johnson M; Perry R H
Transmitters in the developing and senescent human brain.
Annals of the New York Academy of Sciences 1993;695():69-72.
-
1993: Perry E K; Court J A; Johnson M; Smith C J; James V; Cheng A V; Kerwin J M; Morris C M; Piggott M A; Edwardson J A
Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus.
Hippocampus 1993;3(3):307-15.
-
1993: Court J A; Perry E K; Johnson M; Piggott M A; Kerwin J A; Perry R H; Ince P G
Regional patterns of cholinergic and glutamate activity in the developing and aging human brain.
Brain research. Developmental brain research 1993;74(1):73-82.
-
1993: Johnson M; Perry E K; Ince P G; Shaw P J; Perry R H
Autoradiographic comparison of the distribution of [3H]MK801 and [3H]CNQX in the human cerebellum during development and aging.
Brain research 1993;615(2):259-66.
-
1993: Perry E K; Irving D; Kerwin J M; McKeith I G; Thompson P; Collerton D; Fairbairn A F; Ince P G; Morris C M; Cheng A V
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.
Alzheimer disease and associated disorders 1993;7(2):69-79.
-
1993: Kerwin J M; Morris C M; Johnson M; Perry R H; Perry E K
Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence.
Acta anatomica 1993;147(4):216-22.
-
1993: Perry E K; Marshall E; Thompson P; McKeith I G; Collerton D; Fairbairn A F; Ferrier I N; Irving D; Perry R H
Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(3):167-77.
-
1992: Ferrier I N; Perry E K
Post-mortem studies in affective disorder.
Psychological medicine 1992;22(4):835-8.
-
1992: McKeith I G; Perry R H; Fairbairn A F; Jabeen S; Perry E K
Operational criteria for senile dementia of Lewy body type (SDLT).
Psychological medicine 1992;22(4):911-22.
-
1992: Perry E K; Court J A; Johnson M; Piggott M A; Perry R H
Autoradiographic distribution of [3H]nicotine binding in human cortex: relative abundance in subicular complex.
Journal of chemical neuroanatomy 1992;5(5):399-405.
-
1992: McKeith I; Fairbairn A; Perry R; Thompson P; Perry E
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
BMJ (Clinical research ed.) 1992;305(6855):673-8.
-
1992: Kerwin J M; Morris C M; Perry R H; Perry E K
Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
Neuroscience letters 1992;143(1-2):101-4.
-
1992: Piggott M A; Perry E K; Perry R H; Court J A
[3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging.
Brain research 1992;588(2):277-86.
-
1992: Perry E K; Johnson M; Kerwin J M; Piggott M A; Court J A; Shaw P J; Ince P G; Brown A; Perry R H
Convergent cholinergic activities in aging and Alzheimer's disease.
Neurobiology of aging 1992;13(3):393-400.
-
1992: Piggott M A; Perry E K; Sahgal A; Perry R H
Examination of parameters influencing [3H]MK-801 binding in postmortem human cortex.
Journal of neurochemistry 1992;58(3):1001-8.
-
1992: Shaw P J; Ince P G; Johnson M; Perry E K; Candy J M
The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human brainstem in relation to motor neuron disease.
Brain research 1992;572(1-2):276-80.
-
1992: Kerwin J M; Morris C M; Perry R H; Perry E K
Nerve growth factor receptor-like immunoreactivity in the human spinal cord.
Acta anatomica 1992;144(4):348-53.
-
1991: Court J A; Perry E K
Dementia: the neurochemical basis of putative transmitter orientated therapy.
Pharmacology & therapeutics 1991;52(3):423-43.
-
1991: Cheng A V; Ferrier I N; Morris C M; Jabeen S; Sahgal A; McKeith I G; Edwardson J A; Perry R H; Perry E K
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
Journal of the neurological sciences 1991;106(1):50-5.
-
1991: Perry E K; Irving D; Perry R H
Cholinergic controversies.
Trends in neurosciences 1991;14(11):483-4; author reply 485-6.
-
1991: Xuereb J H; Perry R H; Candy J M; Perry E K; Marshall E; Bonham J R
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease.
Brain : a journal of neurology 1991;114 ( Pt 3)():1363-79.
-
1991: Mantle D; Perry E K
Comparison of Ca(2+)-activated proteinase enzyme and endogenous inhibitor activity in brain tissue from normal and Alzheimer's disease cases.
Journal of the neurological sciences 1991;102(2):220-4.
-
1991: Leake A; Perry E K; Perry R H; Jabeen S; Fairbairn A F; McKeith I G; Ferrier I N
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Biological psychiatry 1991;29(4):357-64.
-
1991: Perry E K
Neurotransmitters and diseases of the brain.
British journal of hospital medicine 1991;45(2):73-83.
-
1991: Shaw P J; Ince P G; Johnson M; Perry E K; Candy J
The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human spinal cord.
Brain research 1991;539(1):164-8.
-
1991: Kerwin J; Morris C; Oakley A; Perry R; Perry E
Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus.
Neuroscience letters 1991;121(1-2):178-82.
-
1991: Perry E K; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson J A; Ince P; Blessed G; Irving D
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Annals of the New York Academy of Sciences 1991;640():197-202.
-
1990: Sahgal A; Keith A B; Lloyd S; Kerwin J M; Perry E K; Edwardson J A
Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: potentiation of disruption by scopolamine.
Pharmacology, biochemistry, and behavior 1990;37(4):597-605.
-
1990: Xuereb J H; Candy J M; Perry E K; Perry R H; Marshall E; Bonham J R
Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease.
Neuropathology and applied neurobiology 1990;16(6):477-88.
-
1990: Court J A; Keith A B; Kerwin J M; Perry E K
Fimbria-fornix lesions in aged rats cause increased carbachol-stimulated phosphoinositide hydrolysis in the hippocampus, but no change in muscarinic receptor binding.
Brain research 1990;532(1-2):333-5.
-
1990: Xuereb J H; Perry E K; Candy J M; Bonham J R; Perry R H; Marshall E
Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease.
Journal of the neurological sciences 1990;99(2-3):185-97.
-
1990: Leake A; Perry E K; Perry R H; Fairbairn A F; Ferrier I N
Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
Biological psychiatry 1990;28(7):603-8.
-
1990: Perry E K; Marshall E; Kerwin J; Smith C J; Jabeen S; Cheng A V; Perry R H
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Journal of neurochemistry 1990;55(4):1454-6.
-
1990: Court J A; Piggott M A; Perry E K
Nicotine reduces the binding of [3H]MK-801 to brain membranes, but not via the stimulation of high-affinity nicotinic receptors.
Brain research 1990;524(2):319-21.
-
1990: Mantle D; Perry E K
Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer's disease cases.
Journal of the neurological sciences 1990;98(1):13-20.
-
1990: Kerwin J M; Perry E K; Morris C M; Perry R H
Nerve growth factor receptor-positive fibre pathways in the human neocortex.
Biochemical Society transactions 1990;18(4):661-3.
-
1990: Ghanbari H A; Miller B E; Haigler H J; Arato M; Bissette G; Davies P; Nemeroff C B; Perry E K; Perry R; Ravid R
Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study.
JAMA : the journal of the American Medical Association 1990;263(21):2907-10.
-
1990: Perry R H; Irving D; Blessed G; Fairbairn A; Perry E K
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.
Journal of the neurological sciences 1990;95(2):119-39.
-
1990: Perry E K; Kerwin J; Perry R H; Blessed G; Fairbairn A F
Visual hallucinations and the cholinergic system in dementia.
Journal of neurology, neurosurgery, and psychiatry 1990;53(1):88.
-
1990: Perry E K; Marshall E; Perry R H; Irving D; Smith C J; Blessed G; Fairbairn A F
Cholinergic and dopaminergic activities in senile dementia of Lewy body type.
Alzheimer disease and associated disorders 1990;4(2):87-95.
-
1990: Perry R H; Irving D; Blessed G; Perry E K; Smith C J; Fairbairn A F
Dementia in old age: identification of a clinically and pathologically distinct disease category.
Advances in neurology 1990;51():41-6.
-
1990: Perry E K
Nerve growth factor and the basal forebrain cholinergic system: a link in the etiopathology of neurodegenerative dementias?
Alzheimer disease and associated disorders 1990;4(1):1-13.
-
1990: Perry E K; Smith C J; Court J A; Perry R H
Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Journal of neural transmission. Parkinson's disease and dementia section 1990;2(3):149-58.
-
1990: Xuereb J H; Tomlinson B E; Irving D; Perry R H; Blessed G; Perry E K
Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
Advances in neurology 1990;53():35-40.
-
1989: Perry E
Current advances in research in Alzheimer's disease.
Recenti progressi in medicina 1989;80(12):692-700.
-
1989: Johnson M; Perry R H; Charlton F G; Moses M A; Court J A; Perry E K
Distribution of [3H]MK801 binding in the normal aged human hippocampus.
Brain research 1989;499(1):184-7.
-
1989: Perry E K; Perry R
Amyloid and Alzheimer's disease: a question of specificity.
Neurobiology of aging 1989;10(5):473-4; discussion 477-8.
-
1989: Perry E K; Smith C J; Perry R H; Whitford C; Johnson M; Birdsall N J
Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Journal of chemical neuroanatomy 1989;2(4):189-99.
-
1989: Perry R H; Irving D; Blessed G; Perry E K; Fairbairn A F
Senile dementia of Lewy body type and spectrum of Lewy body disease.
Lancet 1989;1(8646):1088.
-
1989: Smith C J; Court J A; Keith A B; Perry E K
Increases in muscarinic stimulated hydrolysis of inositol phospholipids in rat hippocampus following cholinergic deafferentation are not parallelled by alterations in cholinergic receptor density.
Brain research 1989;485(2):317-24.
-
1989: Mantle D; Lauffart B; Perry E K; Perry R H
Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease.
Journal of the neurological sciences 1989;89(2-3):227-34.
-
1989: Perry R H; Irving D; Blessed G; Perry E K; Fairbairn A F
Clinically and neuropathologically distinct form of dementia in the elderly.
Lancet 1989;1(8630):166.
-
1988: Perry E K; Smith C J; Court J A; Bonham J R; Rodway M; Atack J R
Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro.
Neuroscience letters 1988;91(2):211-6.
-
1988: Perry E
Acetylcholine and Alzheimer's disease.
The British journal of psychiatry : the journal of mental science 1988;152():737-40.
-
1988: Smith C J; Perry E K; Perry R H; Candy J M; Johnson M; Bonham J R; Dick D J; Fairbairn A; Blessed G; Birdsall N J
Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders.
Journal of neurochemistry 1988;50(3):847-56.
-
1987: Smith C J; Perry E K; Perry R H; Fairbairn A F; Birdsall N J
Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease.
Neuroscience letters 1987;82(2):227-32.
-
1987: Atack J R; Perry E K; Bonham J R; Boakes R; Candy J M
Loss and recovery of acetylcholinesterase molecular forms in the fornix-lesioned rat hippocampus.
Neuroscience letters 1987;79(1-2):179-84.
-
1987: Cross A J; Slater P; Simpson M; Royston C; Deakin J F; Perry R H; Perry E K
Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
Neuroscience letters 1987;79(1-2):213-7.
-
1987: McKeith I G; Marshall E F; Ferrier I N; Armstrong M M; Kennedy W N; Perry R H; Perry E K; Eccleston D
5-HT receptor binding in post-mortem brain from patients with affective disorder.
Journal of affective disorders 1987;13(1):67-74.
-
1987: Atack J R; Perry E K; Bonham J R; Perry R H
Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Journal of neurochemistry 1987;48(6):1845-50.
-
1987: Atack J R; Perry E K; Bonham J R; Candy J M; Perry R H
Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system.
Journal of neurochemistry 1987;48(6):1687-92.
-
1987: Perry E K; Perry R H; Smith C J; Dick D J; Candy J M; Edwardson J A; Fairbairn A; Blessed G
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
Journal of neurology, neurosurgery, and psychiatry 1987;50(6):806-9.
-
1987: Taylor G R; Carter G I; Crow T J; Johnson J A; Fairbairn A F; Perry E K; Perry R H
Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation.
Journal of neurology, neurosurgery, and psychiatry 1987;50(3):356.
-
1987: Perry R H; Perry E K; Smith C J; Xuereb J H; Irving D; Whitford C A; Candy J M; Cross A J
Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
Journal of neural transmission. Supplementum 1987;24():131-6.
-
1986: Perry E K; Perry R H; Smith C J; Purohit D; Bonham J; Dick D J; Candy J M; Edwardson J A; Fairbairn A
Cholinergic receptors in cognitive disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):521-7.
-
1986: Perry E K; Smith C J; Atack J R; Candy J M; Johnson M; Perry R H
Neocortical cholinergic enzyme and receptor activities in the human fetal brain.
Journal of neurochemistry 1986;47(4):1262-9.
-
1986: Atack J R; Perry E K; Bonham J R; Candy J M; Perry R H
Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
Journal of neurochemistry 1986;47(1):263-77.
-
1986: Candy J M; Oakley A E; Klinowski J; Carpenter T A; Perry R H; Atack J R; Perry E K; Blessed G; Fairbairn A; Edwardson J A
Aluminosilicates and senile plaque formation in Alzheimer's disease.
Lancet 1986;1(8477):354-7.
-
1986: Taylor G R; Carter G I; Crow T J; Johnson J A; Fairbairn A F; Perry E K; Perry R H
Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization.
Experimental and molecular pathology 1986;44(1):111-6.
-
1986: Perry E K
The cholinergic hypothesis--ten years on.
British medical bulletin 1986;42(1):63-9.
-
1986: Candy J M; Perry E K; Perry R H; Court J A; Oakley A E; Edwardson J A
The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
Progress in brain research 1986;70():105-32.
-
1986: Ferrier I N; McKeith I G; Cross A J; Perry E K; Candy J M; Perry R H
Postmortem neurochemical studies in depression.
Annals of the New York Academy of Sciences 1986;487():128-42.
-
1985: Candy J M; Gascoigne A D; Biggins J A; Smith A I; Perry R H; Perry E K; McDermott J R; Edwardson J A
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Journal of the neurological sciences 1985;71(2-3):315-23.
-
1985: Candy J M; Perry E K; Perry R H; Bloxham C A; Thompson J; Johnson M; Oakley A E; Edwardson J A
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus.
Neuroscience letters 1985;61(1-2):91-5.
-
1985: Atack J R; Perry E K; Perry R H; Wilson I D; Bober M J; Blessed G; Tomlinson B E
Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type.
Journal of the neurological sciences 1985;70(1):1-12.
-
1985: Perry E K; Curtis M; Dick D J; Candy J M; Atack J R; Bloxham C A; Blessed G; Fairbairn A; Tomlinson B E; Perry R H
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(5):413-21.
-
1985: Perry E K; Perry R H
A review of neuropathological and neurochemical correlates of Alzheimer's disease.
Danish medical bulletin 1985;32 Suppl 1():27-34.
-
1984: Perry E K; Perry R H; Candy J M; Fairbairn A F; Blessed G; Dick D J; Tomlinson B E
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
Neuroscience letters 1984;51(3):353-7.
-
1984: Perry R H; Candy J M; Perry E K; Thompson J; Oakley A E
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations.
Journal of anatomy 1984;138 ( Pt 4)():713-32.
-
1984: Cross A J; Crow T J; Johnson J A; Perry E K; Perry R H; Blessed G; Tomlinson B E
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.
Journal of the neurological sciences 1984;64(2):109-17.
-
1984: Perry E K; Atack J R; Perry R H; Hardy J A; Dodd P R; Edwardson J A; Blessed G; Tomlinson B E; Fairbairn A F
Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.
Journal of neurochemistry 1984;42(5):1402-10.
-
1983: Perry E K; Perry R H
Human brain neurochemistry - some postmortem problems.
Life sciences 1983;33(18):1733-43.
-
1983: Perry R H; Tomlinson B E; Candy J M; Blessed G; Foster J F; Bloxham C A; Perry E R
Cortical cholinergic deficit in mentally impaired Parkinsonian patients.
Lancet 1983;2(8353):789-90.
-
1983: Atack J R; Perry E K; Bonham J R; Perry R H; Tomlinson B E; Blessed G; Fairbairn A
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form.
Neuroscience letters 1983;40(2):199-204.
-
1983: Cross A J; Crow T J; Johnson J A; Joseph M H; Perry E K; Perry R H; Blessed G; Tomlinson B E
Monoamine metabolism in senile dementia of Alzheimer type.
Journal of the neurological sciences 1983;60(3):383-92.
-
1983: Candy J M; Perry R H; Perry E K; Irving D; Blessed G; Fairbairn A F; Tomlinson B E
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
Journal of the neurological sciences 1983;59(2):277-89.
-
1983: Perry E K; Marshall E F; Blessed G; Tomlinson B E; Perry R H
Decreased imipramine binding in the brains of patients with depressive illness.
The British journal of psychiatry : the journal of mental science 1983;142():188-92.
-
1983: Biggins J A; Perry E K; McDermott J R; Smith A I; Perry R H; Edwardson J A
Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.
Journal of the neurological sciences 1983;58(1):117-22.
-
1982: Perry R H; Candy J M; Perry E K; Irving D; Blessed G; Fairbairn A F; Tomlinson B E
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
Neuroscience letters 1982;33(3):311-5.
-
1982: Arregui A; Perry E K; Rossor M; Tomlinson B E
Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas.
Journal of neurochemistry 1982;38(5):1490-2.
-
1982: Perry E K; Perry R H; Tomlinson B E
The influence of agonal status on some neurochemical activities of postmortem human brain tissue.
Neuroscience letters 1982;29(3):303-7.
-
1982: Perry R H; Wilson I D; Bober M J; Atack J; Blessed G; Tomlinson B E; Perry E K
Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type.
Lancet 1982;1(8264):174-5.
-
1982: Perry E K; Perry R H
Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1982;Suppl 5():140-5.
-
1981: Dodd P R; Hardy J A; Oakley A E; Edwardson J A; Perry E K; Delaunoy J P
A rapid method for preparing synaptosomes: comparison, with alternative procedures.
Brain research 1981;226(1-2):107-18.
-
1981: Perry R H; Dockray G J; Dimaline R; Perry E K; Blessed G; Tomlinson B E
Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.
Journal of the neurological sciences 1981;51(3):465-72.
-
1981: Perry E K; Oakley A E; Candy J M; Perry R H
Properties and possible significance of substance P and insulin fibrils.
Neuroscience letters 1981;25(3):321-5.
-
1981: Perry E K; Tomlinson B E; Blessed G; Perry R H; Cross A J; Crow T J
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.
Journal of the neurological sciences 1981;51(2):279-87.
-
1981: Perry E K; Tomlinson B E; Blessed G; Perry R H; Cross A J; Crow T T
Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.
Lancet 1981;2(8238):149.
-
1981: Cross A J; Crow T J; Perry E K; Perry R H; Blessed G; Tomlinson B E
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.
British medical journal (Clinical research ed.) 1981;282(6258):93-4.
-
1981: Perry E K; Blessed G; Tomlinson B E; Perry R H; Crow T J; Cross A J; Dockray G J; Dimaline R; Arregui A
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.
Neurobiology of aging 1981;2(4):251-6.
-
1980: Tarbit I; Perry E K; Perry R H; Blessed G; Tomlinson B E
Hippocampal free amino acids in Alzheimer's disease.
Journal of neurochemistry 1980;35(5):1246-9.
-
1980: Richter J A; Perry E K; Tomlinson B E
Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.
Life sciences 1980;26(20):1683-9.
-
1980: Perry E K; Perry R H; Tomlinson B E; Blessed G; Gibson P H
Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase.
Neuroscience letters 1980;18(1):105-10.
-
1980: Perry R H; Blessed G; Perry E K; Tomlinson B E
Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients.
Age and ageing 1980;9(1):9-16.
-
1980: Perry E K
The cholinergic system in old age and Alzheimer's disease.
Age and ageing 1980;9(1):1-8.
-
1978: Perry E K; Tomlinson B E; Blessed G; Bergmann K; Gibson P H; Perry R H
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
British medical journal 1978;2(6150):1457-9.
-
1978: Perry E K; Perry R H; Blessed G; Tomlinson B E
Changes in brain cholinesterases in senile dementia of Alzheimer type.
Neuropathology and applied neurobiology 1978;4(4):273-7.
-
1977: Perry E K; Gibson P H; Blessed G; Perry R H; Tomlinson B E
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
Journal of the neurological sciences 1977;34(2):247-65.
-
1977: Perry E K; Perry R H; Gibson P H; Blessed G; Tomlinson B E
A cholinergic connection between normal aging and senile dementia in the human hippocampus.
Neuroscience letters 1977;6(1):85-9.
-
1977: Perry E K; Perry R H; Taylor M J; Tomlinson B E
Evidence of a circadian fluctuation in neurotransmitter enzyme activities measured in autopsy human brain.
Journal of neurochemistry 1977;29(3):593-4.
-
1977: Perry E K; Perry R H; Tomlinson B E
Dietary lecithin supplements in dementia of Alzheimer type.
Lancet 1977;2(8031):242-3.
-
1977: Perry E K; Perry R H; Taylor M J; Tomlinson B E
Circadian variation in human brain enzymes.
Lancet 1977;1(8014):753-4.
-
1977: Perry E K; Perry R H; Tomlinson B E
Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex.
Neuroscience letters 1977;4(3-4):185-9.
-
1977: Perry E K; Perry R H; Blessed G; Tomlinson B E
Necropsy evidence of central cholinergic deficits in senile dementia.
Lancet 1977;1(8004):189.
-
1977: Perry R H; Tomlinson B E; Taylor M J; Perry E K
Human brain temperature at necropsy: a guide in post-mortem biochemistry.
Lancet 1977;1(8001):38.
Sign-in to see more
